Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Effects of regorafenib (REG) therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial.
PaperCitations, authors & open-access status
Effects of regorafenib (REG) therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2 citations, 2015 year and closed oa status.
2
Citations
2015
Year
closed
OA Status